152 related articles for article (PubMed ID: 35116331)
1. Clinical and biological features of mantle cell lymphoma patients with co-expression of CD10 and BCL-6: a retrospective study.
Chen W; Liu H; Wang P; Li G
Transl Cancer Res; 2021 Nov; 10(11):4786-4793. PubMed ID: 35116331
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review.
Castillo DR; Park D; Jeon WJ; Joung B; Lee J; Yang C; Pham B; Hino C; Chong E; Shields A; Nguyen A; Brothers J; Liu Y; Zhang KK; Cao H
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373354
[TBL] [Abstract][Full Text] [Related]
3. [The Clinical-Biological Features and Prognosis of Patients with Mantle Cell Lymphoma].
Chen WZ; Liu TB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1726-1732. PubMed ID: 38071052
[TBL] [Abstract][Full Text] [Related]
4. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.
Pizzi M; Agostinelli C; Righi S; Gazzola A; Mannu C; Galuppini F; Fassan M; Visentin A; Piazza F; Semenzato GC; Rugge M; Sabattini E
Histopathology; 2017 Nov; 71(5):769-777. PubMed ID: 28628241
[TBL] [Abstract][Full Text] [Related]
6. CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases.
Xu J; Medeiros LJ; Saksena A; Wang M; Zhou J; Li J; Yin CC; Tang G; Wang L; Lin P; Li S
Oncotarget; 2018 Feb; 9(14):11441-11450. PubMed ID: 29545910
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognostic factors of elderly patients with mantle cell lymphoma].
Hao XY; Yang P; Zhang W; Liu H; Sun XH; Xiao XB; Wang JW; Li ZL; Li LH; Wang SY; He J; Li XL; Jing HM
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):495-500. PubMed ID: 37550206
[No Abstract] [Full Text] [Related]
8. Cooccurrence of CD10-Positive and CD10-Negative Mantle Cell Lymphoma Complicated With Central Nervous System Involvement Solely by CD10-Positive Population.
Fukushima N; Mino T; Arihiro K; Ichinohe T
Cureus; 2022 Jan; 14(1):e21341. PubMed ID: 35186599
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.
Colomo L; López-Guillermo A; Perales M; Rives S; Martínez A; Bosch F; Colomer D; Falini B; Montserrat E; Campo E
Blood; 2003 Jan; 101(1):78-84. PubMed ID: 12393466
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and subclassification of follicle center and mantle cell lymphomas on fine-needle aspirates: A cytologic and immunocytochemical approach based on the Revised European-American Lymphoma (REAL) classification.
Rassidakis GZ; Tani E; Svedmyr E; Porwit A; Skoog L
Cancer; 1999 Aug; 87(4):216-23. PubMed ID: 10455210
[TBL] [Abstract][Full Text] [Related]
11. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome.
Zoldan MC; Inghirami G; Masuda Y; Vandekerckhove F; Raphael B; Amorosi E; Hymes K; Frizzera G
Br J Haematol; 1996 May; 93(2):475-86. PubMed ID: 8639452
[TBL] [Abstract][Full Text] [Related]
12. Smoldering mantle cell lymphoma.
Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
[TBL] [Abstract][Full Text] [Related]
13. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
Dunphy CH; Perkins SL
Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and prognostic analysis of mantle cell lymphoma patients].
Zhou P; Shi Y; He X; Zhou S; Liu P; Dong M; Qin Y; Yang J; Zhang C; Zhou L; Yang S; Gui L
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):928-32. PubMed ID: 25623769
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic features and prognosis of gastrointestinal mantle cell lymphoma].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):763-768. PubMed ID: 30317731
[No Abstract] [Full Text] [Related]
16. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
17. Patterns of survival in mantle cell lymphoma.
Zucca E; Roggero E; Pinotti G; Pedrinis E; Cappella C; Venco A; Cavalli F
Ann Oncol; 1995 Mar; 6(3):257-62. PubMed ID: 7612491
[TBL] [Abstract][Full Text] [Related]
18. CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.
Akhter A; Mahe E; Street L; Pournazari P; Perizzolo M; Shabani-Rad MT; Stewart DA; Mansoor A
J Clin Pathol; 2015 Oct; 68(10):844-8. PubMed ID: 26124315
[TBL] [Abstract][Full Text] [Related]
19. [Relationship of Expression of Circ_cgga162 with the Prognosis of Patients with Mantle Cell Lymphoma].
Li Y; Jia ZW; Liu JX; Ye JW; Kong XY; Yang ZF; Liu XY; Luo JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):876-880. PubMed ID: 32552951
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Characteristics and Prognosis of 34 Patients with Mantle Cell Lymphoma: A Retrospective Analysis].
Chen XP; Zhao Y; Wang QS; Lv N; Li YH; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1601-6. PubMed ID: 26708879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
